Policy

CEO discusses consolidation in health care.

Physicians, hospitals weigh in on health-related judgment.

How lawmakers can regulate PBMs.

Regarding Medicare physician reimbursement, Marshall says doctors should ‘ask them why they're cutting your pay.’

The broken fee-for-service model, in combination with CMS’ efforts to contain costs, promises to cripple our health care delivery system unless providers transition to a value-based care model – and soon.

Physicians Advocacy Institute comments on federal request for information about consolidation in health care.

Analysts ponder value, transparency and the effects of the Inflation Reduction Act.

The ruling is going to be difficult to interpret and enforce.

Physicians group leaders comment as part of annual gathering this month.

Unpacking vaccine pricing: navigating policy, economics, and public health imperatives.

New study finds uneven progress in making data exchange easier and more useful

Rep. Greg Murphy, MD, discusses prior authorizations and other pending legislation in Washington.

Abortion and AI also in the mix at the national level.

Critics air concerns at White House roundtable as pharmacy benefit manager volley back.

More than half of the nation’s state top lawyers pen letter to leaders in House and Senate.

Change takes effect in 2025 and could benefit more than one million Medicare beneficiaries

A new advocacy organization for independent physicians.

A new advocacy organization for independent physicians.

A new advocacy organization for independent physicians.

A new advocacy organization for independent physicians.

A new advocacy organization for independent physicians.

PhRMA, U.S. Chamber warn of unintended consequences, market effects of negotiations.

Administration, HHS tout milestone day on road to lowering drug prices for beneficiaries.

A new advocacy organization for independent physicians.

A new advocacy organization for independent physicians.

A new advocacy organization for independent physicians.

A new advocacy organization for independent physicians.

A new advocacy organization for independent physicians.

It's time for pharmaceutical companies and others to innovate and disrupt the distribution side of treatment.

AIMPA intends to become a new voice for physicians in independent practice.